RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 100 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $920,347 | +263609.7% | 40,146 | +89.5% | 0.06% | +181.0% |
| Q2 2023 | $349 | -65.9% | 21,183 | -63.1% | 0.02% | -66.7% |
| Q1 2023 | $1,023 | -40.8% | 57,335 | -3.3% | 0.06% | -41.1% |
| Q4 2022 | $1,727 | -99.9% | 59,298 | +14.5% | 0.11% | +28.9% |
| Q3 2022 | $1,269,000 | +482.1% | 51,802 | -1.4% | 0.08% | +492.9% |
| Q2 2022 | $218,000 | -64.5% | 52,519 | -1.5% | 0.01% | -57.6% |
| Q1 2022 | $614,000 | +17.9% | 53,300 | +2.1% | 0.03% | +26.9% |
| Q4 2021 | $521,000 | -18.5% | 52,212 | +6.7% | 0.03% | -23.5% |
| Q3 2021 | $639,000 | +1.4% | 48,950 | +52.1% | 0.03% | 0.0% |
| Q2 2021 | $630,000 | -6.5% | 32,193 | +1.6% | 0.03% | -15.0% |
| Q1 2021 | $674,000 | – | 31,688 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |